BackgroundCheck.run
Search For

Johnny W Peterson, 77League City, TX

Johnny Peterson Phones & Addresses

League City, TX   

Pittsburg, TX   

3709 Pabst Rd, Dickinson, TX 77539    281-5342811   

La Marque, TX   

Encino, CA   

Galveston, TX   

Work

Company: Apex diversified solutions 2013 Position: Fleet dispatch representative

Education

School / High School: Sam Houston State Univ 1994

Mentions for Johnny W Peterson

Resumes & CV records

Resumes

Johnny Peterson Photo 38

Independent Executive

Location:
Houston, Texas Area
Industry:
Health, Wellness and Fitness
Johnny Peterson Photo 39

Johnny Peterson

Johnny Peterson Photo 40

Johnny Peterson

Skills:
Management
Johnny Peterson Photo 41

Johnny Peterson

Johnny Peterson Photo 42

Johnny Peterson

Johnny Peterson Photo 43

Johnny Peterson

Johnny Peterson Photo 44

Johnny Peterson

Johnny Peterson Photo 45

Sales At Champion Rentals

Location:
Houston, Texas Area
Industry:
Construction

Publications & IP owners

Us Patents

Methods And Compositions To Inhibit Edema Factor And Adenylyl Cyclase

US Patent:
8003692, Aug 23, 2011
Filed:
Jun 13, 2008
Appl. No.:
12/139212
Inventors:
Catherine H. Schein - Friendswood TX, US
Johnny W. Peterson - Dickinson TX, US
Scott R. Gilbertson - Galveston TX, US
Deliang Chen - League City TX, US
Mary A. Walter - Fair Oaks Ranch TX, US
Jian Gao - Helotes TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
Mission Pharmacal Co. - San Antonio TX
International Classification:
A61K 31/195
A61K 31/192
A61K 31/381
A61K 31/343
A61K 31/403
US Classification:
514468, 514443, 514441, 514563, 514615
Abstract:
Fluorene-based molecules and their derivatives are described in compositions for the treatment of intestinal fluid loss.

Heterocycle Derivatives And Methods Of Use

US Patent:
2002003, Mar 14, 2002
Filed:
May 19, 2001
Appl. No.:
09/860652
Inventors:
Johnny Peterson - Dickinson TX, US
Deborah Gessell-Lee - Galveston TX, US
Shamsher Saini - Dickinson TX, US
International Classification:
A61K031/5575
A61K031/4164
US Classification:
514/396000, 514/559000
Abstract:
The present invention provides methods for treating intestinal fluid loss, whooping cough, anthrax, and conditions associated with smooth muscle contraction. The present invention also provides methods for inhibiting adenylate cyclase in vivo and in vitro.

Plap Polypeptides And Methods Of Producing And Using Same

US Patent:
2003016, Sep 4, 2003
Filed:
Jun 19, 2002
Appl. No.:
10/175270
Inventors:
Johnny Peterson - Dickinson TX, US
Shamsher Saini - Galveston TX, US
Thomas Wood - Houston TX, US
Ashok Chopra - Galveston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61K038/17
G01N033/53
US Classification:
514/012000, 435/007100
Abstract:
Synthetic milittin and related peptides derived from the sequence of human phospholipase A-activating protein (PLAP), free from the contaminating phospholipase A(PLA) and/or present when the peptides are purified from natural sources, show inhibitory activity against PLA. Inhibition of this enzyme, responsible for the hydrolysis of arachiodonate, an important precursor of eicosanoids, should lead to a decrease in the inflammatory response. In addition to their use as anti-inflammatory therapeutics, compositions containing the synthetic peptides may also be useful therapeutic tools for diagnosing inflammatory diseases (e.g., Crohn's disease, ulcerative colitis, rheumatoid arthritis).

Methods And Compositions To Inhibit Edema Factor And Adenylyl Cyclase

US Patent:
2012001, Jan 12, 2012
Filed:
Jun 7, 2011
Appl. No.:
13/154923
Inventors:
Catherine H. Schein - Friendswood TX, US
Scott R. Gilbertson - Galveston TX, US
Johnny W. Peterson - Dickinson TX, US
Deliang Chen - League City TX, US
Mary A. Walter - Fair Oaks Ranch TX, US
Jian Gao - Helotes TX, US
Assignee:
Board of Regents, The University of Texas - Austin TX
Mission Pharmacal Co. - San Antonio TX
International Classification:
A61K 31/438
A61K 31/196
A61P 31/04
C07C 229/60
C07C 229/52
A61K 31/24
A61K 31/122
C07D 471/04
US Classification:
514290, 514690, 514577, 514300, 546122, 562458, 560 48, 514535
Abstract:
Small molecules and their derivatives are described for the treatment and/or prevention of intestinal fluid loss. Also disclosed are methods of using said molecules and their derivatives to treat and/or prevent conditions associated with increased levels of 3′,5′-adenosine monophosphate. Specific compositions of the invention are also novel.

Dietary Supplement Containing Histidine For Alleviating Dysmenorrhea, Endometriosis, And Pre-Term Labor

US Patent:
6211221, Apr 3, 2001
Filed:
Apr 5, 1999
Appl. No.:
9/285717
Inventors:
Johnny W. Peterson - Dickinson TX
Peter G. Thomas - Charlottesville VA
International Classification:
A61K 31415
US Classification:
514399
Abstract:
The present invention relates to methods for alleviating disorders or chronic conditions of the female reproductive system, such as dysmenorrhea, endometrial pain, and pre-term labor, through dietary supplementation with histidine. The invention relates further to novel combination supplements of histidine in conjunction with other nutritional supplement materials which are preferably also useful in alleviating the above-mentioned disorders or conditions. A method for administering a dietary histidine supplement in conjunction with one or more separately formulated therapeutic drugs also known to be useful in treating these female reproductive conditions is also disclosed.

Colony Blot Assay For Enterotoxigenic Bacteria

US Patent:
4617265, Oct 14, 1986
Filed:
Sep 19, 1984
Appl. No.:
6/652369
Inventors:
Johnny W. Peterson - Dickinson TX
Assignee:
Board of Regents, University of Texas System - Austin TX
International Classification:
C12Q 110
G01N 5300
US Classification:
435 38
Abstract:
A plate of suitable nutrient medium and agar is inoculated with bacteria from a biological sample. Bacterial colonies are cultured on the plate and are then overlaid with a soft agar layer containing bacterial lysing agents. A removable sheet with bound first animal antibodies for cholera toxin is used to contact the overlaid lysed colonies. The sheet is then exposed to a second animal antibody to cholera toxin followed by treatment with a third animal antibody against the second animal antibody, said third animal antibody being coupled to an enzyme capable of generating a chromophoric product. The sheet is then developed by immersion in a substrate and system for the bound enzyme to produce chromophoric products at the sites of enterotoxigenic bacterial colonies.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.